COVID - 19 Vaccination Update - Day 496 - Prevention is better than cure

Spread the Message

Read Time:1 Minute, 40 Second

Posted On: 26 MAY 2022 8:29PM by PIB Delhi

India’s COVID-19 vaccination coverage has crossed 192.95 Crore (1,92,95,87,987) today. More than 12 lakh (12,62,771) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs	1^st Dose	10406766
	2^nd Dose	10037666
	Precaution Dose	5176206
FLWs	1^st Dose	18418688
	2^nd Dose	17579933
	Precaution Dose	8569365
Age Group 12-14 years	1^st Dose	33450264
	2^nd Dose	15403624
Age Group 15-18 years	1^st Dose	59342715
	2^nd Dose	45321233
Age Group 18-44 years	1^st Dose	557021402
	2^nd Dose	488861162
	Precaution Dose	718707
Age Group 45-59 years	1^st Dose	203225983
	2^nd Dose	190587075
	Precaution Dose	1294941
Over 60 years	1^st Dose	127074028
	2^nd Dose	118856913
	Precaution Dose	18241316
Cumulative 1^st dose administered		1008939846
Cumulative 2^nd dose administered		886647606
Precaution Dose		34000535
Total		1929587987

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 26^th May, 2022 (496^th Day)
HCWs	1^st Dose	39
	2^nd Dose	632
	Precaution Dose	10817
FLWs	1^st Dose	64
	2^nd Dose	1129
	Precaution Dose	32616
Age Group 12-14 years	1^st Dose	136489
	2^nd Dose	257467
Age Group 15-18 years	1^st Dose	36506
	2^nd Dose	105128
Age Group 18-44 years	1^st Dose	31901
	2^nd Dose	309737
	Precaution Dose	28643
Age Group 45-59 years	1^st Dose	5460
	2^nd Dose	69501
	Precaution Dose	24980
Over 60 years	1^st Dose	3747
	2^nd Dose	48369
	Precaution Dose	159546
Cumulative 1^st dose administered		214206
Cumulative 2^nd dose administered		791963
Precaution Dose		256602
Total		1262771

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.